Literature DB >> 18543051

Histogenetic characterization of giant cell tumor of bone.

Manuela Salerno1, Sofia Avnet, Marco Alberghini, Armando Giunti, Nicola Baldini.   

Abstract

The unpredictable behavior of giant cell tumor (GCT) parallels its controversial histogenesis. Multinucleated giant cells, stromal cells, and CD68(+) monocytes/macrophages are the three elements that interact in GCT. We compared the ability of stromal cells and normal mesenchymal stromal cells to differentiate into osteoblasts. Stromal cells and mesenchymal cells had similar proliferation rates and lifespans. Although stromal cells expressed early osteogenic markers, they were unable to differentiate into osteoblasts but they did express intracellular adhesion molecule-1, a marker of bone-lining cells. They were unable to form clones in a semisolid medium and unable to promote osteoclast differentiation, although they exerted a strong chemotactic effect on osteoclast precursors. Stromal cells may be either immature proliferating osteogenic elements or specialized osteoblast-like cells that fail to show neoplastic features but can induce the differentiation of osteoclast precursors. They might be secondarily induced to proliferate by a paracrine effect induced by monocyte-macrophages and/or giant cells. The increased number of giant cells in GCT may be secondary to an autocrine circuit mediated by the receptor activator of nuclear factor kB.

Entities:  

Mesh:

Year:  2008        PMID: 18543051      PMCID: PMC2492994          DOI: 10.1007/s11999-008-0327-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  45 in total

1.  Osteoid formation in giant cell tumors of bone.

Authors:  R M SHUFFSTALL; J E GREGORY
Journal:  Am J Pathol       Date:  1953 Nov-Dec       Impact factor: 4.307

2.  Malignant osteoclastoma.

Authors:  J A P CAMERON; A T H MARSDEN; K LUMPUR
Journal:  J Bone Joint Surg Br       Date:  1952-02

3.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

4.  Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone.

Authors:  M H Zheng; P Siu; J M Papadimitriou; D J Wood; A R Murch
Journal:  Pathology       Date:  1999-11       Impact factor: 5.306

5.  Prognostic relevance of C-myc gene expression in giant-cell tumor of bone.

Authors:  G Gamberi; M S Benassi; T Böhling; P Ragazzini; L Molendini; M R Sollazzo; M Merli; C Ferrari; G Magagnoli; F Bertoni; P Picci
Journal:  J Orthop Res       Date:  1998-01       Impact factor: 3.494

6.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

7.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

8.  Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases.

Authors:  E W Brien; J M Mirra; S Kessler; M Suen; J K Ho; W T Yang
Journal:  Skeletal Radiol       Date:  1997-04       Impact factor: 2.199

9.  Cbfa1 isoforms exert functional differences in osteoblast differentiation.

Authors:  H Harada; S Tagashira; M Fujiwara; S Ogawa; T Katsumata; A Yamaguchi; T Komori; M Nakatsuka
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

10.  Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells.

Authors:  Y Tanaka; S Mine; T Hanagiri; T Hiraga; I Morimoto; C G Figdor; Y van Kooyk; H Ozawa; T Nakamura; K Yasumoto; S Eto
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

View more
  13 in total

1.  Intratibial injection of patient-derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse.

Authors:  Leqin Xu; Zhipeng Wu; Zhenhua Zhou; Xinghai Yang; Jianru Xiao
Journal:  Oncol Lett       Date:  2018-07-16       Impact factor: 2.967

2.  miR-181c associates with tumor relapse of high grade osteosarcoma.

Authors:  Federica Mori; Andrea Sacconi; Valeria Canu; Federica Ganci; Mariangela Novello; Vincenzo Anelli; Renato Covello; Virginia Ferraresi; Paola Muti; Roberto Biagini; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2015-06-10

3.  Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.

Authors:  Mika Terasaki; Yasuhiro Terasaki; Kyoko Wakamatsu; Naomi Kuwahara; Koichi Yoneyama; Rieko Kawase; Keisuke Kurose; Etsuko Toda; Yoko Endo; Shinobu Kunugi; Yusuke Kajimoto; Akira Shimizu
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

4.  Differentially expressed genes in giant cell tumor of bone.

Authors:  Erica Babeto; André Luis Giacometti Conceição; Marina Curado Valsechi; Paulo Peitl Junior; Débora Aparecida Pires de Campos Zuccari; Luiz Guilherme Cernaglia Aureliano de Lima; Jane Lopes Bonilha; Marília de Freitas Calmon; José Antônio Cordeiro; Paula Rahal
Journal:  Virchows Arch       Date:  2011-02-09       Impact factor: 4.064

5.  A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases.

Authors:  Ira J Miller; Alan Blank; Suellen M Yin; Allison McNickle; Robert Gray; Steven Gitelis
Journal:  Diagn Pathol       Date:  2010-09-22       Impact factor: 2.644

Review 6.  Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.

Authors:  Yuhree Kim; Saqib Nizami; Hana Goto; Francis Y Lee
Journal:  Clin Orthop Surg       Date:  2012-05-17

7.  Clinical outcome in Giant cell tumor of cervico-thoracic spine: Our experience with three cases.

Authors:  Jagdeep Singh; Raj Bahadur; Sorabh Garg; Karan Rajpal; Karan Chopra
Journal:  Int J Surg Case Rep       Date:  2020-05-29

8.  Pediatric Upper Cervical Spine Giant Cell Tumor: Case Report.

Authors:  Mohammad D Alfawareh; Irfanullah D Shah; Tamer I Orief; Mohammad M Halawani; Walid I Attia; Khaled N Almusrea
Journal:  Global Spine J       Date:  2014-12-17

9.  Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.

Authors:  Matthew R Steensma; Wakenda K Tyler; Allison G Shaber; Steven R Goldring; F Patrick Ross; Bart O Williams; John H Healey; P Edward Purdue
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 10.  Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.

Authors:  Kemal Behzatoglu
Journal:  Pathol Oncol Res       Date:  2021-04-30       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.